Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 0.4649 USD 2.63% Market Closed
Market Cap: $55.2m

Accuray Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Accuray Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Accuray Inc
NASDAQ:ARAY
Free Cash Flow
-$2.7m
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$3.7B
CAGR 3-Years
57%
CAGR 5-Years
30%
CAGR 10-Years
35%
Edwards Lifesciences Corp
NYSE:EW
Free Cash Flow
$1.3B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Free Cash Flow
$4.3B
CAGR 3-Years
28%
CAGR 5-Years
9%
CAGR 10-Years
20%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$7.4B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$2.5B
CAGR 3-Years
37%
CAGR 5-Years
17%
CAGR 10-Years
13%
No Stocks Found

Accuray Inc
Glance View

Market Cap
55.2m USD
Industry
Health Care

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

ARAY Intrinsic Value
4.1075 USD
Undervaluation 89%
Intrinsic Value
Price $0.4649

See Also

What is Accuray Inc's Free Cash Flow?
Free Cash Flow
-2.7m USD

Based on the financial report for Dec 31, 2025, Accuray Inc's Free Cash Flow amounts to -2.7m USD.

What is Accuray Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
62%

Over the last year, the Free Cash Flow growth was 62%. The average annual Free Cash Flow growth rates for Accuray Inc have been 62% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett